ReviewCurrent oncology reports2024
Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?
Ilana Schlam et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewCurrent oncology reports2024
Ilana Schlam et al.PubMed ↗Publisher ↗
No numbers read from the abstract.